Impact factor: 6.840
Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Each issue covers topics such as COPD, asthma, smoking, respiratory infection and lung cancer.
Thorax is delighted to announce its new impact factor of 6.840, retaining its 2nd position ranking in the category of the Respiratory System.
Airwaves now free!
For a quick overview of the top articles in this month's issue, take a look at Airwaves written by the Thorax Editors.
You can now keep up to date with the latest Editor's choice and Unlocked articles via the Thorax Twitter account
This month Thorax considers the number needed to treat (NNT) in COPD with the following free paper:
Number needed to treat in COPD: exacerbations versus pneumonias >>
Click here to view all the latest BTS guidelines published in Thorax, and the latest BTS abstract book
Listen to the latest podcast from Thorax for the TB special March issue: